Who owns TRAVERE THERAPEUTICS INC?
- CUSIP Number: 89422gab3
Tip: Access positions for across all investors
Analyze quarterly positions in Travere Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Travere Therapeutics stock
Who bought or sold TRAVERE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ing Investment Management | 98M | $116M | 100% | Jun 2026 |
|
| BlackRock | 51M | $60M | 100% | Jun 2026 |
|
| Context Capital Management | 51M | $60M | 100% | Jun 2026 |
|
| Calamos Advisors | 49M | $58M | 100% | Jun 2026 |
|
| Polar Securities | 31M | $36M | 100% | Jun 2026 |
|
| Tenor Capital Management | 28M | $33M | 100% | Jun 2026 |
|
| Wellesley Investment Advisors | 24M | $26B | 100% | Jun 2026 |
|
| Lord, Abbett & Co | 18M | $21M | 100% | Jun 2026 |
|
| Lazard Asset Management | 16M | $188k | 100% | Jun 2026 |
|
| Steelhead Partners | 15M | $18B | 100% | Jun 2026 |
|
| M&G | 14M | $16M | 100% | Jun 2026 |
|
| Citadel Advisors | 12M | $14M | 100% | Jun 2026 |
|
| Ameriprise Financial | 9.9M | $12M | 100% | Jun 2026 |
|
| DeepCurrents Investment Group | 7.3M | $8.6M | 100% | Jun 2026 |
|
| D. E. Shaw & Co | 6.5M | $7.6M | 100% | Jun 2026 |
|
| Linden Advisors | 6.3M | $7.4M | 100% | Jun 2026 |
|
| BlueCrest Capital Management | 6.0M | $7.1M | 100% | Jun 2026 |
|
| Advent Capital Management | 5.3M | $6.2M | 100% | Jun 2026 |
|
| OrbiMed Advisors | 5.0M | $5.9M | 100% | Jun 2026 |
|
| Millennium Management | 4.8M | $5.6M | 100% | Jun 2026 |
|
| State of Wisconsin Investment Board | 4.0M | $4.7M | 100% | Jun 2026 |
|
| Jpmorgan Chase & Co | 3.5M | $4.2M | 100% | Jun 2026 |
|
| Invesco | 2.5M | $2.9M | 100% | Jun 2026 |
|
| Shenkman Capital Management | 2.3M | $2.7B | 100% | Jun 2026 |
|
| Man Group | 1.9M | $2.2M | 100% | Jun 2026 |
|
| FMR | 1.7M | $2.0M | 100% | Jun 2026 |
|
| Agf Management | 1.3M | $1.5M | 100% | Jun 2026 |
|
| RWC Asset Management | 1.3M | $1.5M | 100% | Jun 2026 |
|
| Tpg Gp A | 1.0M | $1.2M | 100% | Jun 2026 |
|
| Nomura Asset Management International | 700k | $825k | 100% | Jun 2026 |
|
| Ares Systematic Credit | 700k | $823k | 100% | Jun 2026 |
|
| Two Sigma Investments | 500k | $588k | 100% | Jun 2026 |
|
| Kohlberg Kravis Roberts & Co | 400k | $471k | 100% | Jun 2026 |
|
| SSI Investment Management | 305k | $358k | 100% | Jun 2026 |
|
| Bank of New York Mellon | 250k | $294k | 100% | Jun 2026 |
|
| UBS Group | 155k | $182k | 100% | Jun 2026 |
|
| Calamos Wealth Management | 103k | $122k | 100% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 85k | $100k | 100% | Jun 2026 |
|
| Loomis, Sayles and | 85k | $4.8M | 100% | Jun 2026 |
|
| Cetera Investment Advisers | 21k | $25k | 100% | Jun 2026 |
|
| Rsm Us Wealth Management | 13k | $15k | 100% | Jun 2026 |
|
| HPM Partners | 11k | $13k | 100% | Jun 2026 |
|
| ADAR1 Capital Management | 10k | $1.0M | 100% | Jun 2026 |
|
| Fifth Third Bancorp | 9.0k | $11k | 100% | Jun 2026 |
|